Sebag IA, Gillis MA, Calderone A, Kasneci A, Meilleur M, Haddad R, Noiles W, Patel B, Chalifour LE. Sex hormone control of left ventricular structure/function: mechanistic insights using echocardiography, expression, and DNA methylation analyses in adult mice. Am J Physiol Heart Circ Physiol 301: H1706 -H1715, 2011. First published July 29, 2011; doi:10.1152/ajpheart.00088.2011.-Calcium flux into and out of the sarco(endo)plasmic reticulum is vitally important to cardiac function because the cycle of calcium entry and exit controls contraction and relaxation. Putative estrogen and androgen consensus binding sites near to a CpG island are present in the cardiac calsequestrin 2 (CSQ2) promoter. Cardiomyocytes express sex hormone receptors and respond to sex hormones. We hypothesized that sex hormones control CSQ2 expression in cardiomyocytes and so affect cardiac structure/function. Echocardiographic analysis of male and female C57bl6n mice identified thinner walled and lighter hearts in females and significant concentric remodeling after long-term gonadectomy. CSQ2 and sodium-calcium exchanger-1 (NCX1) expression was significantly increased in female compared with male hearts and decreased postovariectomy. NCX1, but not CSQ2, expression was increased postcastration. CSQ2 expression was reduced when H9c2 cells were cultured in hormone-deficient media; increased when estrogen receptor-␣ (ER␣), estrogen receptor-␤ (ER␤), or androgen agonists were added; and increased in hearts from ER␤-deficient mice. CSQ2 expression was reduced in mice fed a diet low in the methyl donor folic acid and in cells treated with 5-azadeoxycytidine suggesting an involvement of DNA methylation. DNA methylation in CpG in the CSQ2 CpG island was significantly different in males and females and was additionally changed postgonadectomy. Expression of DNA methyltransferases 1, 3a, and 3b was unchanged. These studies strongly link sex hormone-directed changes in CSQ2 expression to DNA methylation with changed expression correlated with altered left ventricular structure and function. protein expression; cardiac function MAINTENANCE OF THE EXPRESSION of calcium homeostasis is important for normal cardiac function (1, 13). Contraction is the consequence of the release of massive amounts of calcium into the cytosol from the sarco(endo)plasmic reticulum (SER) by ryanodine receptor 2. Relaxation is established by the combined action of the sodium-calcium exchanger-1 (NCX1) (30), which removes calcium to the cell exterior, and the sarco(endo)plasmic reticulum ATPase 2a (SERCA2a), which resequesters calcium back to the SER (19). Phospholamban (PLB) inhibits SERCA2a activity, but phosphorylation on either serine 16 (S 16 ) or threonine 17 (T 17 ) relieves this inhibition. Calsequestrin 2 (CSQ2) may be uniquely important for calcium signaling because it is the principal calcium storage protein in the SER and, as part of a protein complex with the ryanodine receptor 2, helps to control the amount of calcium released for contraction (7).
resequesters calcium back to the SER (19) . Phospholamban (PLB) inhibits SERCA2a activity, but phosphorylation on either serine 16 (S 16 ) or threonine 17 (T 17 ) relieves this inhibition. Calsequestrin 2 (CSQ2) may be uniquely important for calcium signaling because it is the principal calcium storage protein in the SER and, as part of a protein complex with the ryanodine receptor 2, helps to control the amount of calcium released for contraction (7) .
The available evidence suggests that sex hormones are involved in regulating cardiac gene expression, modulate the response to cardiac stresses, and may play a protective role against calcium overload (5, 31, 32, 33, 35, 36, 2, 15) . Damage from ischemia-reperfusion has been linked to increased calcium. Female hearts show reduced damage after ischemiareperfusion than male hearts (9) . Female rodents demonstrate smaller calcium transients and have reduced cardiac reserve, smaller changes in shortening, and less SER calcium loading compared with males after a catecholamine challenge (6, 10, 28, 38) . Baseline expression of calcium homeostasis proteins differs in male and female rats, and these differences were translated into differences in in vitro force development and relaxation (8) . Ovariectomized (OVX) rats are hypersensitive to changes in calcium that is relieved by estradiol (35) , and isolated cardiomyocytes from OVX hearts showed slow relaxation and contraction kinetics (5) . Androgens are also involved. Castration of adult rats led to an 80% reduction in NCX1 mRNA that was reversed, albeit with nonphysiological levels, of testosterone (17) . These androgen-starved cardiomyocytes also had longer relaxation times suggesting that the lower NCX1 level caused reduced calcium clearance from the cytosol.
In this study, we show sex-and hormone-specific differences in left ventricular structure/function in older C57bl/6n mice. We show differences in the expression of calcium homeostasis proteins that reflect sex and hormone status. Further, using CSQ2 as a particularly important protein and representative of sex steroid modulation, we show sex-and hormone-dependent differences in DNA CpG methylation within the CSQ2 promoter. We conclude that sex hormones maintain sex-specific patterns of calcium homeostasis protein expression and cardiac structure and function. We propose sex-and hormone-dependent alterations in DNA methylation are part of the mechanism to maintain sexdependent gene expression. These are the first studies to comprehensively examine the mechanism of regulation of calcium homeostasis protein expression and cardiac structure/function by sex hormones.
MATERIALS AND METHODS

Animals.
Animal experimentation was performed according to the guidelines of the Canadian Council on Animal Care and was reviewed and approved by the Lady Davis Institute/Sir Mortimer B. DavisJewish General Hospital Animal Care Committee. Age-matched 7-to 8-mo-old male and female C57Bl/6n mice (n ϭ 10 -16 per group; Charles River Canada) were randomly assigned to either an intact or gonadectomized (GDX) group. Surgery was performed while the animals were under 2% isoflurane anesthesia. Carprofen (5 mg/kg) was given as analgesia. Ten to eleven weeks later, animals underwent cardiac function analyses. One week later they were anesthetized with 2% isoflurane, blood was collected for hormone analyses by cardiac puncture, and they were euthanized and hearts and other organs were weighed. Serum estradiol was measured by ELISA following the manufacturer's instructions (Assay Designs). Estrogen receptor-␤-deficient male mice (ER␤KO; n ϭ 6; average age ϳ9 mo) were a gift from Dr. Celine Fiset (Institut du Cardiologie de Montréal, Montréal). Hearts from Balb/c male mice fed prepared normal or folic acid deficient diets (n ϭ 3 per group) and C57bl6/n mice (n ϭ 4 per group) fed normal, folic acid deficient, or folic acid enriched diets (25) for 10 wk were gifts from Dr. Rima Rosen (Montreal Children's Hospital, Montreal).
Echocardiography. C57bl/6n mice were anesthetized with 2% isoflurane, the chest area was shaved, and electrocardiographic electrode patches were attached. Images were acquired from the parasternal short-axis view at the midventricular level with a 14-mHz, i13L linear-array transducer (Vivid 7; GE Medical Systems) at a frame rate of 100 frames per second and a depth of 1 cm. Heart rates averaged 560 Ϯ 40 beats/min and did not vary with sex or treatment. Left ventricular (LV) dimensions and septal and posterior wall thicknesses were measured offline using M-mode acquisitions. Measurements were gathered from three consecutive beats from three independent acquisitions using the leading edge-to-leading edge technique and EchoPac (GE Systems) software.
Millar catheterization. C57bl/6n mice were anesthetized with 2% isoflurane. Pressure and left ventricular function were measured with a microtip pressure transducer catheter (1.4 French; Millar Instruments, Houston, TX) advanced through the carotid artery to the left ventricle. Heart rates averaged 480 Ϯ 45 beats/min. Data were analyzed with the program IOX version 1.8.0 (EMKA Technologies, Falls Church, VA).
Gene expression analyses. Portions of the ventricular hearts were homogenated in RIPA buffer [50 mM Tris pH, 7.4, 150 mM NaCl, 0.5% Na deoxycholate, 0.1% NP10, 0.1% SDS, 1ϫ complete proteinase inhibitor cocktail (Roche), 10 mM Na metabisulfite, 10 mM PMSF, 10 mM Na vanadate, and 1 mM okadaic acid]. The homogenate was left on ice for 2 h and then clarified by microcentrifugation in the cold. Total protein was measured using the Bradford assay against BSA. Ten to twenty micrograms of protein in SDS loading buffer (62.5 mM Tris pH 6.8, 2% wt/vol SDS, 10% glycerol, 50 mM DTT, and 0.01% wt/vol bromophenol blue) was electrophoresed through SDS-PAGE and then electrophoretically transferred to Immobilon P (Millipore). Membranes were stained with Ponceau S to verify equivalent loading and transfer, blocked in TBST ϩ 5% skim milk powder (10 mM Tris pH 7.5, 150 mM NaCl, and 0.01% Tween 20) at room temperature and incubated with primary antibody overnight in the cold. Primary antibodies were commercially available [GAPDH, NCX1, CSQ2, calreticulin (CRT), PLB, phospho-serine 16-specific PLB (pS 16 -PLB, collagen III, Affinity BioReagents, Golden, CO), phospho-threonine 17-specific PLB (pT 17 -PLB, Badrilla, UK), DNA methyltransferase (DNMT)1, DNMT3a, DNMT3b (Abcam, Cambridge, MA), and collagen I (Calbiochem)]. An antibody to SERCA2a (Dr. F. Wuytack, Belgium) was a gift. Membranes were treated with species-specific secondary antibodies complexed to horseradish peroxidase. and the reaction was revealed using enhanced chemiluminescent detection kits from Pierce (Rockford, IL). Several exposures from each membrane were collected onto X-ray film. After immunoblotting, membranes were washed and then stained with Coomassie brilliant blue, destained, and scanned.
Hormone manipulation of cardiac differentiated H9c2 cells. Genomic DNA from H9c2 cells was purified by high salt extraction and ethanol precipitation. Cell DNA was amplified for 35 cycles by Taq DNA polymerase and X-and Y-chromosome-specific primers (5=-CCA CTG CCA AAT TCT TTG G-3= and 5-=CTG AAG CTT TTG GCT TTG AG-3=) using an annealing temperature of 54°C. Amplified DNA of 301 and 331 bp indicates a male; a single band at 331 bp indicates a female.
H9c2 cells were cardiac differentiated by culture in normal media (DMEM ϩ 1% FBS) or hormone-depleted media (phenol red-free DMEM ϩ 1% charcoal-stripped FBS) plus daily addition of 10 Ϫ8 M retinoic acid for 4 days. 17-␤-Estradiol (E2; Sigma-Aldrich, St. Louis, MI), the ER␤-specific agonist 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN; Tocris, Ellisville, MI), the ER␣-specific agonist 4,4=,4=-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT; Tocris), testosterone proprionate (Test P.; Sigma-Aldrich), cyproterone acetate (CPA; Sigma-Aldrich), or vehicle was added to the differentiation media. On day 5, cells were lysed in SDS loading buffer and clarified by centrifugation and immunoblots were performed. Immunoblots were repeated three times from each of three independent culture experiments.
CpG methylation analyses of ventricle DNA. Genomic DNA, from n ϭ 5 animals per group, was purified from C57bl/6n mouse ventricular heart by high salt extraction and ethanol precipitation. DNA was treated with sodium bisulfite using the EpiTect bisulfite kit, (Qiagen, Mississauga, ON) according to the manufacturer's instructions. Aliquots were amplified by Taq DNA polymerase and the CSQ2-specific primers 5=-TATTGGTAGGGGATTTGTTGA-3=and 5=-AACCACA-CAAAAAAAAAAACC-3= using an initial annealing temperature of 42°C for one cycle followed by 34 cycles at 50°C. A 1-l aliquot was then amplified with primers 5=-GGGATTTGTTGAATAAGAAGTT-3= and 5=-AAACCCTTAAAAACAATAACCA-3= for 35 cycles with an annealing temperature of 57°C. Amplified DNA was cloned into the pGEM-T vector (Qiagen). Five or more clones per animal were sequenced using an automated sequencer (McGill Genome Centre, Montreal, QC, Canada).
Statistical analyses. X-ray films and membranes were scanned using an HP Scanjet 5100C and HP Precision Scan Software (Hewlett-Packard, Palo Alto, CA). The areas under the peaks were quantified using ScionImage Release Beta 3 Software (National Institutes of Health, Bethesda, MD). A two-way ANOVA design with repeated measurements was used when comparing multiple cohorts, and one-way ANOVA and Student's t-test analyses were used with pairs. A P value Ͻ 0.05 was considered significant.
RESULTS
Physiological parameters. Age-matched cohorts from intact or GDX adult male and female C57Bl/6n mice were prepared. We chose to use sexually mature and older (7-8 mo) mice to maximize the impact of the sex hormones on cardiac parameters and to model mid-aged biological aging. With increasing age, female C57bl/6 mice enter an estropause characterized by a low persistent estrogen levels, show varying length of cyclicity after ϳ12 mo, and transition to an true acyclic anestrous state at ϳ16 to 18 mo of age (27) . Wet heart weight was not significantly different between the sexes when indexed to tibia length (Table 1) . To determine how long-term hormone deprivation alters the sex-specific cardiac function and expression patterns, we prepared OVX, castrated (CAS) cohorts of the sexually mature, and older mice. We examined cardiac function by echocardiography after 4 and 10 wk, concluding with Millar catheterization and euthanasia. We chose a 10-wk hormone deficiency time period as sufficient to be considered long yet to end before any initiation of an estropause in the intact female cohorts (12) . We chose to age-match the intact and GDX mice to remove age as a confounder in our study. Indexed wet heart weight after GDX was similar to that of the intact cohort. Successful ovarian excision was confirmed by a substantial decrease in uterine weight (P Ͻ 0.001) and lower serum estradiol (P Ͻ 0.001).
Cardiac structure and function analyses. Echocardiography analyses was performed at 4 and 10 wk and Millar catheterization at 11 wk postgonadectomy in the four treatment groups to measure cardiac structure/function (Fig. 1) . Intact, OVX, and CAS mice were age matched. Echocardiography identified significantly reduced intraventricular septum diastole (IVSd; P Ͻ 0.008) and left ventricle posterior wall diastole (LVPWd; P Ͻ 0.001), fractional shortening (FS; P Ͻ 0.001), ejection fraction (EF; P Ͻ 0.001), calculated left ventricle mass (cLVM; P Ͻ 0.005), and relative wall thickness (RWT; P Ͻ 0.001) in the intact female vs. intact male hearts.
Four weeks post-GDX, the OVX cohort had reduced FS (P Ͻ 0.03) and a trend to reduced EF (P ϭ 0.051) but no change in IVSd, reduced left ventricle inner diameter diastole (LVIDd), RWT, or cLVM in OVX compared with intact female mice. After 10 wk, the OVX group had significantly increased IVSd (P Ͻ 0.02), reduced LVIDd (P Ͻ 0.0045), and increased RWT (P Ͻ 0.001) and cLVM (P Ͻ 0.003) when compared with intact females. After 4 wk of CAS, mice showed reduced LVIDd (P Ͻ 0.01) and reduced FS (P Ͻ 0.01) and EF (P Ͻ 0.01) when compared with intact males, whereas LVIDd, RWT, and cLVM were unchanged. At 10 wk, the CAS group had increased LVPWd (P Ͻ 0.001), reduced LVIDd (P Ͻ 0.02), and increased calculated RWT (P Ͻ 0.001) but no change in the cLVM when compared with intact males. Therefore, after long-term absence of sex hormones, both OVX and CAS groups demonstrate concentric remodeling when compared with age-matched and hormone-replete intact mice. When compared directly, the echocardiographic measurements in the OVX and CAS animals were similar after 10-wk hormone deprivation. Thus echocardiography identified sexspecific heart structure changes and the development of concentric remodeling with time post-GDX.
Millar catheterization was performed to measure contractile function (Fig. 1B) . Intact females had significantly lower mean blood pressure than intact males (P Ͻ 0.003). OVX and CAS mice demonstrated no difference in blood pressure compared with their intact counterparts. Although the first maximal derivative of left ventricular pressure (ϩdP/dt) and first minimal derivative of left ventricular pressure (ϪdP/dt) were significantly decreased in intact females compared with intact males (P Ͻ 0.017 and P Ͻ 0.004, respectively), these parameters remained unchanged following OVX or CAS.
Collagen I protein expression was increased significantly (P Ͻ 0.03) in OVX compared with intact female mice (Fig. 1C) . Collagen III expression did not vary with sex or hormone status.
Expression of calcium homeostasis proteins in vivo. We measured the expression of proteins important in SER calcium flux in cardiac homogenates of intact male and female C57bl/ 6n mice to determine how sex affects expression. NCX1, SERCA2a, CSQ2, CRT, PLB, pS 16 -PLB, and pT 17 -PLB expression was measured in relation to GAPDH expression in ventricular homogenates ( Fig. 2A) . Intact females had significantly higher NCX1 and CSQ2 and decreased CRT protein expression compared with intact males. Both sexes had similar expression levels of SERCA2a and PLB. pT 17 -PLB expression was equivalent, but pS 16 -PLB was significantly increased in female hearts.
To determine how long-term hormone deficiency affected expression, we compared protein expression in ventricular homogenates of age-matched intact vs. OVX females (Fig. 2B ) and age-matched intact vs. CAS males (Fig. 2C ). NCX1 and CSQ2 expression after OVX was significantly decreased (P Ͻ 0.017 and P Ͻ 0.001, respectively) with no change in CRT, SERCA2a, PLB, or pS 16 -PLB expression ( Fig. 2A) . pT 17 -PLB expression was increased in the OVX hearts. In contrast, NCX1 expression was increased after CAS (P Ͻ 0.001), but there were no changes in SERCA2a, CSQ2, CRT, or total PLB expression. The levels of both pS 16 -PLB (P Ͻ 0.002) and pT 17 -PLB (P Ͻ 0.002) were decreased after CAS (Fig. 2B) . The results suggest significant and sex-specific changes in NCX1 and CSQ2 expression when hormones are deficient due to long-term GDX.
Hormonal control of CSQ2 expression in vitro and in ER␤KO mice. We used the cardiac cell line H9c2 and ER␤-deficient mice to measure how changes in hormone levels in vitro or lack of ER␤ signaling in vivo affected the expression of proteins involved in calcium homeostasis. H9c2 cells have a female genotype (Fig. 3A) . When H9c2 cells were cardiac differentiated in hormone-depleted media, CSQ2 expression was reduced (P Ͻ 0.001), but the expression of other proteins involved in calcium homeostasis was unaffected (Fig. 3B ). 17␤-E 2 (ER␣ and ER␤ agonist), DPN (ER␤-specific agonist), and PPT (ER␣ agonist) were added to the differentiation media. CSQ2 expression was restored by 17␤-E 2 , ER␣ (PPT), and ER␤ (DPN) specific agonists (Fig. 3C ). CSQ2 expression was increased (P Ͻ 0.03) in male ER␤KO mice when compared with age-matched C57Bl/6n mice (Fig. 3D) . The ER␤KO mice used have a C57bl/6n background and were not hypertensive. CSQ2 expression was decreased by Test P. (Test P. at 10 Ϫ7 M; P Ͻ 0.03; Fig. 4E ). Coadministration of Test P. and a 100-fold excess of the anti-androgen cCPA increased CSQ2, although not to control levels. The data show positive regulation of CSQ2 expression by sex hormones in cardiomyocytes is present in vitro and indicate that ER␤ receptor signaling is involved in CSQ2 regulation in vivo. Uterine weight, mg
Values are means Ϯ SE. Mice were anesthetized, cardiac puncture was performed to collect serum for estrogen measurements, and mice were then euthanized. Body weight, heart weight, and tibia length were measured on all animals, and testes or uterus weights were collected as appropriate. *P Ͻ 0.05, male vs. female; †P Ͻ 0.05, intact male vs. castrated (CAS); ‡P Ͻ 0.05, intact female vs. ovariectomized (OVX).
Methylation of CpG pairs in the cardiac CSQ2 promoter DNA in vivo.
Proteins that modify chromatin and DNA are components of the sex hormone:receptor complex. We showed previously that cardiac differentiated H9c2 cells treated with the DNA methylation inhibitor 5-azadeoxycytidine had reduced CSQ2 expression (23) . Reductions in the diet of the one-carbon donor, folic acid, reduce global DNA methylation, particularly in Balb/c mice (25) . To determine how reductions in global DNA methylation influence CSQ2 expression in vivo, we measured CSQ2 expression in protein homogenates of hearts from Balb/c male mice fed a normal or folic acid deficient diet. CSQ2 expression was significantly reduced with folic acid deficiency (Fig. 4A) . To more directly compare with our results, C57bl/6n mice were fed normal, folate-deficient, or folate-supplemented diets for 10 wk and CSQ2 expression was measured. Cardiac CSQ2 expression was reduced in C57bl/6n mice fed a folate-deficient diet. To determine if sex and hormone status altered DNA methyltransferase levels, we measured DNA methyltransferases 1, 3a, and 3b expression in C57bl/6n mice (Fig. 4B) . Expression was similar in all the cohorts suggesting that although sex and hormone status did not influence DNMT expression in vivo in adult heart, a global change in DNA methylation affected CSQ2 expression.
In silico analysis of the mouse cardiac CSQ2 promoter using Transfac and MethylPrimer identified consensus bipartite and single ER binding sites and a CpG island [Ϫ1,342 to Ϫ1,227; (15)]. Activating protein-1 consensus binding sites bracket the CpG island (Fig. 4, C and D) . To determine how sex and hormone status affect the methylation status of CpG pairs within the CSQ2 CpG island, we isolated genomic DNA from ventricle tissue and compared the methylation pattern of individual CpG pairs (Fig. 4D) . Methylation in females was significantly reduced at CpG pair 3 (Ϫ37%, P Ͻ 0.003) and 7 (Ϫ32%, P Ͻ 0.013), with a tendency for reduction at CpG 6 (Ϫ24%) when compared with intact males. After OVX, methylation was significantly increased at CpG pair 3 (ϩ58%, P Ͻ 0.001), when compared with intact females. After CAS, methylation was significantly reduced at CpG pairs 3 (Ϫ35%, P Ͻ 0.009) and 4 (Ϫ48%, P Ͻ 0.04) when compared with intact males. When OVX and CAS methylation patterns were compared, significant differences were present at CpG 3 (OVX increased 55%, P Ͻ 0.008), 4 (OVX increased 46%, P Ͻ 0.04) and 8 (OVX increased 20%, P Ͻ 0.002). Sequence analyses identified sex-dependent and hormone-dependent CpG methylation, particularly at CpG site 3, within the CSQ2 promoter.
DISCUSSION
Cardiac structure with sex and hormone status. To our knowledge, this is the first comprehensive examination of the role of sex hormones in the control of cardiac structure/ Fig. 2 . Expression of calcium homeostasis proteins in male and female C57Bl/6n mice. A: adult 9-to 10-mo-old C57Bl/6n male and female mice (n Ͼ 6 per group) were euthanized and hearts were removed. Immunoblots were performed as indicated in MATERIALS AND METHODS. Line across the bar graph at 1 indicates the expression level in intact male mice. B and C: adult 5-to 7-mo-old C57Bl/6n mice were left intact or GDX (n Ͼ 6 per group). Ten weeks later animals were euthanized, and hearts were homogenized. B: comparison of intact and OVX females. C: comparison of intact and CAS males. Expression was normalized to that of GAPDH. Representative blots are shown. Experiments used 6 mice per sex and Ն3 repetitions of the blotting for each protein on each mouse homogenate. Bar graphs show the average and the SE of immunoblot repetitions. NXC1, sodium-calcium exchanger-1; CSQ, calsequestrin 2; CRT, calreticulin; SERCA2a, sarco(endo)plasmic reticulum ATPase 2a; PLB, phospholamban. *P Ͻ 0.05, significant difference. Line across the bar graph at 1 indicates the expression level present in sex-appropriate intact mice. function, calcium homeostasis protein expression, and DNA methylation in mature C57bl/6n mice. Our echocardiographic and macroscopic data support the finding of thinner walls, decreased left ventricular mass, and decreased heart function in the mature females compared with similarly aged males. We used a single inbred mouse line, C57bl/6n, so we cannot generalize to other inbred mouse lines; however, our data support the idea that sexual maturity and aging alter cardiac structure in mice, as they do in humans (11, 26) . Intact female C57bl/6 mice have the greatest fertility up to 7 mo but are considered to be midreproductive at 12-14 mo (13) after which cycle length can vary and eventually lead to ovarian decline and lost cycling ability. Our intact female mice averaged 11 mo of age at the time of analysis and so would be considered to be of midreproductive fecundity. Our hormone deprivation period was selected to be 10 wk and thus our GDX female were aged to Ͻ12 mo to ensure that in our comparisons of the GDX to our intact female mice that a substantial loss of ovarian function would not be a confounder in our intact mice and to ensure that our intact and GDX mice would be age matched. Our data are Fig. 3 . Expression of calcium homeostasis proteins in cardiac differentiated H9c2 cells. A: genomic DNA was isolated from H9c2 cells and amplified using sex-specific primers. Amplified DNA was electrophoresed, and DNA was stained with ethidium bromide and photographed. ϩcF used DNA isolated from female mice; ϩcM used DNA isolated from male mice. B: H9c2 cells were cardiac differentiated in 1% normal (N) or 1% hormone-depleted (HD) FBS. Immunoblots on the lysed cells were performed as described in MATERIALS AND METHODS. Expression was normalized to that of the Coomassie-stained membrane after all blotting was completed. Line across the bar graph is the level of expression in normal media artificially designated as 1. C: vehicle, 17␤-estrogen (E2), 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN), or 4,4=,4=-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) was added to HD media at the indicated concentrations when cardiac differentiation was initiated. Drug:receptor specificities are as follows: 17␤-estradiol [estrogen receptor (ER)␣ and ER␤ agonist], DPN (ER␤-specific agonist), and PPT (ER␣-specific agonist). CSQ expression was measured 96 h later as described in MATERIALS AND METHODS. Results represent 3 independent culture experiments. D: adult ER␤KO or C57Bl/6n (WT) male mice (n ϭ 5 per group) were euthanized and protein homogenates generated from ventricular hearts. CSQ expression was measured as described in MATERIALS AND METHODS with normalization to GAPDH. Representative blots are shown with bar graphs indicating the average and standard error of repetitions. *P Ͻ 0.05, significant difference. E: vehicle, testosterone proprionate (Test P.), or Test P. plus 100-fold excess cyproterone acetate (CPA) was added to HD media at the indicated concentrations when cardiac differentiation was initiated. RM, regular media. CSQ expression was measured 96 h later as described in MATERIALS AND METHODS. Results represent 3 independent experiments. Fig. 4 . DNA methylation of the cardiac CSQ2 promoter in vivo. A, left: Balb/c mice (n ϭ 3 per group) were fed a folic acid replete (Norm.) or folic acid deficient (Fol. Def) diet for 10 wk. Right: C57bl/6n mice (n ϭ 4) per group were fed Norm, Fol. Def, or folic acid enriched (Fol. Enr.) diet for 10 wk. Mice were euthanized and the hearts obtained and homogenized. CSQ2 expression was measured as described in MATERIALS AND METHODS and compared with GAPDH expression. Representative blots are shown with bar graphs indicating the average and SE of 3 repetitions. *P Ͻ 0.05, significant difference compared with Norm. B: heart homogenates from C57bl/6n intact male, intact female, OVX, and CAS (n ϭ 3 per group) were immunoblotted using the indicated antibodies. DNA methyltransferase (DNMT) expression was measured as described in MATERIALS AND METHODS with normalization to GAPDH. Bar graphs indicate the average and SE of 3 repetitions. C: partial DNA sequence of the mouse CSQ2 promoter (GenBank AC166072) showing ER consensus binding sites in bold and italic; activating protein-1 sites in bold and the CSQ2 CpG island in italics. CpG pairs are numbered. D: CSQ2 CpG island is schematically shown as a black box. Individual CpG pairs are numbered and their relative placement indicated by vertical rectangles. E: percent methylation at individual CpG pairs was measured after cloning and sequencing Ն5 separate clones from bisulfite-treated DNA from 2 independent isolations of heart sample DNA from n Ͼ 4 C57bl/6n mice per group. *P Ͻ 0.05, male vs. female; &P Ͻ 0.05, intact male vs. CAS; $P Ͻ 0.05, intact female vs. OVX and ϩ OVX vs. CAS.
consistent with the idea that continued hormone exposure is necessary to maintain a sex-specific cardiac structure. Both sexes developed concentric remodeling after GDX. The increased wall thickness/left ventricular mass, and consequent reduction in LVIDd, after ovariectomy are likely a compensatory mechanisms that serve to maintain fractional shortening. We also observed an increase in RWT in CAS vs. intact males, not to a degree, however, that translated into a significant increase in calculated left ventricular mass. Female and male mice have significantly different maximum and minimum dP/dt, and this difference was maintained post-GDX. Concentric remodeling is known to increase dP/dt (16) . In GDX females, the lack of a dP/dt increase despite new concentric remodeling suggests that there is impaired myocardial contractility. In GDX males, the increased RWT and depressed FS are also suggestive of impaired myocardial contractility. This impaired contractility may be conducive to further deterioration of heart function with time, under continued hormone deprivation. Collagen I expression was increased in OVX mice whereas collagen III expression did not vary with sex or hormone status. Increased collagen I expression is suspected of being an early indicator of later fibrosis. Its increased expression here in the OVX cohort suggests that this relatively long period of hormone deprivation led to some degree of detectable fibrosis. We did not measure the compliance of resistance or other vessels in the mice and so cannot comment on the role of sex or hormone deprivation in vessels contributing to the observed changes in cardiac function. The data suggest that in mice cardiac function deteriorates with time when female sex hormones are absent. Thus the echocardiographic and hemodynamic data suggest that male and female hearts are dissimilar and are affected post-GDX. We conclude that there are distinct sex-specific changes in cardiac structure and function in these older mice.
Calcium homeostasis protein expression with sex. The sexspecific differences in cardiac structure/function are likely a consequence of sex-and hormone-specific differences in the expression of proteins, such as those important in calcium homeostasis. Our results suggest that females and males generate and maintain calcium homeostasis by distinct sex-specific regulation. The increased CSQ2 and reduced CRT in females suggest that total calcium storage capacity is similar in males and females. However, the higher CSQ2 in females suggests a greater capacity to store calcium is present in the SER and more calcium is available for contraction. To our knowledge, this is the first instance of modulation of CSQ2 and CRT in normal animals, perhaps reflecting the older age of these mice. NCX1 may be more important for calcium extrusion and relaxation in females than males. We found significantly increased NCX1 protein in intact female hearts than male hearts. Differences in the cardiac phenotype of gene modified NCX1 male and female mice support the idea of a greater dependence on NCX1 for calcium extrusion in females than males (20, 31) . NCX1 Ϫ/Ϫ females are more likely than NCX1 Ϫ/Ϫ males to develop heart failure postpressure overload, and NCX1 Ϫ/Ϫ females are prone to heart failure postpartum. It is important to note though that NCX1 is projected to play a relatively minor role in calcium transport in rodents because it was estimated to account for only 7% of calcium transport in male rats (2) . SERCA2a and PLB expression was similar in males and females; however, the increase in pS 16 -PLB in the females suggests less inhibition of SERCA2a activity in the females than males perhaps permitting greater calcium reentry into the SER. Our studies extend the results previously shown in rats where changes in NCX1, L-type calcium channel, and ryanodine receptor 2 expression in females relative to males (8) were correlated with differences in in vitro force development and relaxation. The conclusion is that sex influences the relative importance of proteins in maintaining calcium homeostasis. The echocardiographic data imply reduced cardiac function in females, i.e., lower FS and EF than males, yet the expression data, i.e., higher NCX1 and CSQ2 and increased phosphoPLBto-PLB ratio, would suggest better cardiac function would be present in the females than males. It has to be noted that none of the mice were stressed and that these are baseline acquisitions suggesting that these results represent normal cardiac function and expression for this age and sex. Therefore, we extend the idea that normal cardiac function indexes are not only specific to an inbred strain but also to age and sex. For an example of the effect of inbred line, when young C57bl/6 and A/J male and female mice were compared, females had reduced LVIDd, LVPWd, IVSd, and LVM and a trend towards reduced FS in both strains (21) . When the two inbred lines were compared with each other, C57bl/6 mice had reduced FS, reduced RWT, increased LVIDd and wall thicknesses, a greater heart mass and better exercise tolerance (21, 24) . Despite these differences, the calculated cardiac index was similar for the two strains. The C57bl/6 mice were equated to have an "athlete's heart" when compared with A/J mice, yet the C57bl/6 mice were not deliberately exercised. Similarly, when healthy and unstressed young male C57bl/6 and SV129 mice were compared, the SV129 mice had significantly reduced FS and EF yet had similar SERCA2a and NCX1 activity coupled to increased SER Ca 2ϩ content (32) . The greater SER Ca 2ϩ content might have been predicted to result in better calcium release, especially at low SR load, and greater FS in the SV129 mice; however, this was not found. For an example of the impact of age and sex, Howlet (22) recently showed smaller contractions, calcium transients, and excitation-coupling gains in young females than young males but also found fractional shortening and excitation-coupling gain to decline significantly in males and not females with increasing age. Additional factors, such as metabolism and vessel function among others, may also contribute to overall cardiac function and vary with age, sex, and inbred line. For example, C57bl/6 mice are more susceptible to the development of metabolic syndrome-like physiology with high-fat diets than A/J mice (33) . The results point to the substantial influence of inbred line, sex, and age on cardiac structure, function, and expression.
Calcium homeostasis protein expression with hormone status. Both sexes exhibited concentric remodeling after GDX and altered protein expression when compared with intact mice. The changes in post-OVX and post-CAS cardiac structure (concentric remodeling) and expression (decreased NCX1 and CSQ2 in OVX and increased NCX1 in CAS) show that the continued presence of sex hormones is necessary to maintain a sex-specific cardiac structure and calcium homeostasis protein expression. Specifically, our data suggest that sex hormones directly or indirectly modulate NCX1 and CSQ2 expression. Our results are consistent with the idea that post-OVX females have a reduced reliance on NCX1 and now show a greater dependence on SERCA2a activity to extrude calcium. SERCA2a and PLB expression was unchanged, but we found increased phosphorylation at pT 17 -PLB suggesting an increase SERCA2a activity post-OVX. We speculate that a change in the PLB phosphorylation state, which affects SERCA2a activity, is compensatory and indirect and is a consequence of hormone directed reductions in NCX1 and CSQ2. Other studies showed reduced L-type calcium channel expression (3), slowed relaxation in isolated cardiomyocytes (5) , and reduced calcium sensitivity in isolated trabecular filaments (39) post-OVX. The data suggest that calcium homeostasis is impaired when either estrogen or ERs and thus downstream signaling is absent. Our in vitro study is similar to the results of Grohe et al. (18) and supports the idea that cardiomyocytes respond directly to sex hormones. CSQ2 was reduced in H9c2 cells cultured in hormone-depleted media but was restored in a nonmonotonic bell-shaped dose-response curve when ER␣ or ER␤ agonists were supplied. ER␤-deficient mice were shown to be more susceptible than ER␣ or wild-type mice to ischemia-reperfusion injury (14) , and the suggestion was that ER␤ signaling may be particularly important for cardioprotection from calcium overload. Our data suggest that part of that mechanism may be that ER␤ signaling normally represses CSQ2 expression in vivo. Thus in the presence of ER receptors in vitro ligand increased CSQ2 expression whereas in the absence of ER␤ downstream signaling CSQ2 was increased. These data suggest additional factors, perhaps cardiac-specific ER binding proteins, influence and dictate the response to ligand and CSQ2 expression. CSQ2 expression was reduced when the nonmetabolizable androgen Test P. was added to H9c2 cells. The increase with estrogen and decrease with androgen correlate with the relative higher amount of CSQ2 expressed in intact female vs. intact male hearts.
Our data extend the results of androgen action on cardiac protein expression. We found increased NCX1 but no change in SERCA2a, PLB, CSQ2, or CRT post-CAS. This is in contrast to an 80% reduction in NCX1 mRNA after short-term castration in rats (17) but similar to the results of Tsang et al. (36) who also found no detectable change in SERCA2a, CSQ2, CRT, or PLB expression with castration. We found decreased pS 16 -PLB and pT 17 -PLB post-CAS. This supports the argument that although SERCA2a and PLB protein levels were unchanged, SERCA2a activity might be decreased post-CAS because of a relative increase in unphosphorylated PLB. It this vein, Tsang et al. found testosterone to enhance pS 16 PLB phosphorylation in isolated male cardiomyocytes. The increase in NCX1 in these males would be expected to compensate for reduced SERCA2a activity. Our results suggest maintenance of calcium storage capacity but a greater reliance on NCX1 to permit relaxation is present after long-term castration. Overall, the combined evidence argues that cardiomyocytes are estrogen and androgen responsive and that NCX1 and CSQ2 are sex hormone targets.
DNA methylation at the CSQ2 promoter is altered by sex and hormone status. Our data show a significant correlation among sex, hormone status, DNA methylation, and CSQ2 expression in adult heart. In the brain, DNA methylation is dynamic and alterable by physiological and dietary interventions (4, 40) . Similar to those studies, we show dynamic DNA methylation at specific cardiac CSQ2 CpG sites in DNA isolated from heart, which is altered by sex and hormone status. When specific CpG sites were analyzed, intact females had reduced CpG methylation in CpG site 3 of the CSQ2 promoter with OVX increasing CpG pair methylation. The opposite was found in males, where CpG methylation at CpG site 3 was reduced post-CAS. In general, greater DNA methylation leads to due to reduced transcription factor binding and activation (34) . We found higher expression levels of CSQ2 expression in intact females compared with intact males, which correlates with their lower DNA methylation in the CSQ2 CpG site 3. In hormone-depleted mice, the reduced CSQ2 protein in the OVX mice compared with the intact females correlates with an increase in DNA methylation in the CSQ2 CpG site 3. We conclude that a detailed analysis of expression and specific CpG pairs shows that the general rule of increased expression and reduced DNA methylation is followed when specific CpG pairs are examined but not when global DNA methylation is manipulated. Alteration of global DNA methylation, both in vitro after incubation with the DNA methylation inhibitor 5=-deoxyazacytidine (23) and in vivo in folic acid deficient mice, reduced cardiac CSQ2 expression. All three DNMTs were expressed similarly in our cohorts suggesting that that difference in DNA methylation are unlikely to be due to differences DNMT levels and that these proteins are not the regulated by sex hormones in heart.
Transcriptional activation or repression involves close interplay with protein and DNA-modifying proteins at the target DNA. ER and androgen receptors act as ligand-activated transcription factors and bring coactivators and corepressors to specific consensus binding sites (29, 41) . In the osteosarcoma cell line U2OS, only a ligand bound ER␤ complex, also bound to nuclear receptor coactivator 2, activated CSQ expression (37) . We speculate that ER delivery of DNA-modifying proteins to the CSQ2 promoter is part of the mechanism that controls hormone-dependent CSQ2 expression. These data indicate that DNA methylation is dynamic in heart, as it is in brain, and that sex hormone action is necessary to maintain a sex-dependent DNA methylation pattern at specific CpG pairs in the CSQ2 promoter.
Limitations to the study. Because we used a single inbred mouse line, C57bl/6n, we cannot generalize to other inbred mouse lines. We did not measure the compliance of resistance or other vessels in the mice and so cannot comment on the role of sex or hormone deprivation in vessels that might contribute to changes in cardiac function. We did not measure cardiac function using ex vivo methods such as the Langendorf technique, so our study is limited to in vivo cardiac function comparisons. Our data can only suggest that in mice cardiac function deteriorates with time when female sex hormones are absent because our maximum time period of GDX was 10 wk and not longer.
We conclude that estrogens and androgens modulate cardiac structure and function and cardiac calcium homeostasis protein expression at least partly through changes in DNA methylation. We conclude that baseline calcium handling is different in males and females and speculate that this might affect remodeling with stress and pathology.
